Ccl2-KO Mouse
一般名
Ccl2-KO
製品ID
S-KO-04225
背景情報
C57BL/6NCya
系統ID
KOCMP-20296-Ccl2-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Ccl2-KO Mouse（カタログ番号S-KO-04225）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ccl2-KO
系統ID
KOCMP-20296-Ccl2-B6N-VA
遺伝子名
製品ID
S-KO-04225
遺伝子別名
JE, HC11, MCAF, MCP1, MCP-1, Scya2, Sigje, SMC-CF
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 11
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000000193
NCBIトランスクリプトID
NM_011333
ターゲット領域
Exon 1~3
有効領域の大きさ
~1.5 kb
遺伝子研究の概要
Ccl2, also known as monocytic chemotactic protein 1 (MCP-1), is an integral chemotactic factor belonging to the CC chemokine family. It recruits macrophages for the immune response by binding to its receptors such as CCR2, ACKR1, and ACKR2, and thus participates in multiple biological processes including inflammation, tissue remodeling, and angiogenesis [2,8].
The CCL2-CCR2 axis has been implicated in numerous disease conditions. In cardiovascular diseases like heart failure, atherosclerosis, and hypertension, laboratory data suggest its role in the disease development and progression, yet clinical translation remains a challenge [1]. In normal and pathological pregnancies, abnormal CCL2 levels are associated with adverse outcomes such as spontaneous abortion and preeclampsia [2]. In cancer, the activation of the CCL2/CCR2 axis promotes the migration of macrophages with an immune-suppressive phenotype, cancer progression, and metastasis [3,4,7]. Also, in obesity and metabolic diseases, this axis influences the genesis and progression of metabolic syndrome [6]. In neuropathic pain, a nerve injury-specific lncRNA promotes pain by increasing Ccl2 expression [5]. In cerebral ischemia-reperfusion injury, CCL2/CCR2 is involved in the pathological process, with increased expression in the acute phase promoting neuroinflammation and in the later phase participating in neuroblast migration [9].
In conclusion, Ccl2 is crucial in immune-related processes and inflammation. Through studies, mainly in various disease models, the CCL2-CCR2 axis has been shown to play significant roles in cardiovascular diseases, pregnancy-related disorders, cancer, obesity-related metabolic diseases, neuropathic pain, and cerebral ischemia-reperfusion injury. These findings from different disease models help in understanding the functions of Ccl2 and potentially developing targeted therapies.
References:
1. Zhang, Haixia, Yang, Ke, Chen, Feng, Li, Lan, Fan, Guanwei. 2022. Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications. In Frontiers in immunology, 13, 975367. doi:10.3389/fimmu.2022.975367. https://pubmed.ncbi.nlm.nih.gov/36110847/
2. Lin, Zhi, Shi, Jia-Lu, Chen, Min, Li, Ming-Qing, Shao, Jun. 2023. CCL2: An important cytokine in normal and pathological pregnancies: A review. In Frontiers in immunology, 13, 1053457. doi:10.3389/fimmu.2022.1053457. https://pubmed.ncbi.nlm.nih.gov/36685497/
3. Hao, Qiongyu, Vadgama, Jaydutt V, Wang, Piwen. 2020. CCL2/CCR2 signaling in cancer pathogenesis. In Cell communication and signaling : CCS, 18, 82. doi:10.1186/s12964-020-00589-8. https://pubmed.ncbi.nlm.nih.gov/32471499/
4. Pozzi, Sabina, Satchi-Fainaro, Ronit. 2024. The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine. In Advanced drug delivery reviews, 209, 115318. doi:10.1016/j.addr.2024.115318. https://pubmed.ncbi.nlm.nih.gov/38643840/
5. Du, Shibin, Wu, Shaogen, Feng, Xiaozhou, Davidson, Steve, Tao, Yuan-Xiang. . A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression. In The Journal of clinical investigation, 132, . doi:10.1172/JCI153563. https://pubmed.ncbi.nlm.nih.gov/35775484/
6. Wu, Yue, Ma, Yanchun. 2024. CCL2-CCR2 signaling axis in obesity and metabolic diseases. In Journal of cellular physiology, 239, e31192. doi:10.1002/jcp.31192. https://pubmed.ncbi.nlm.nih.gov/38284280/
7. Kadomoto, Suguru, Izumi, Kouji, Mizokami, Atsushi. 2021. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment. In International journal of molecular sciences, 22, . doi:10.3390/ijms22168530. https://pubmed.ncbi.nlm.nih.gov/34445235/
8. Singh, Sanjiv, Anshita, D, Ravichandiran, V. 2021. MCP-1: Function, regulation, and involvement in disease. In International immunopharmacology, 101, 107598. doi:10.1016/j.intimp.2021.107598. https://pubmed.ncbi.nlm.nih.gov/34233864/
9. Geng, Huixia, Chen, Luna, Tang, Jing, Chen, Yi'ang, Wang, Lai. 2022. The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials. In International journal of molecular sciences, 23, . doi:10.3390/ijms23073485. https://pubmed.ncbi.nlm.nih.gov/35408846/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。